Huanhuan Zhang

发表

Cytokine-induced killer cell therapy for modulating regulatory T cells in patients with non-small cell lung cancer.

Chengzhi Zhou, Jun Xu, Chenyun He, 2017, Experimental and therapeutic medicine.

Erlotinib: An enhancer of radiation therapy in nasopharyngeal carcinoma

Jian Li, Yin Liang, Huanhuan Zhang, 2013, Experimental and therapeutic medicine.

microRNA-125b reverses the multidrug resistance of nasopharyngeal carcinoma cells via targeting of Bcl-2.

Yin Liang, Huanhuan Zhang, Tai-Ze Yuan, 2017, Molecular medicine reports.

Prognostic impact of pretreatment serum superoxide dismutase activity in patients with locoregionally advanced nasopharyngeal carcinoma

Yawei Yuan, J. Jiang, K. Liao, 2022, The International journal of biological markers.

A 46-year-old Chinese woman presenting with retroperitoneal follicular dendritic cell sarcoma: a case report

Xiu-Hui Zhang, Huanhuan Zhang, Jian Li, 2014, Journal of Medical Case Reports.

Expression of MTA1 in nasopharyngeal carcinoma and its correlation with prognosis

Qiong Zhang, Yin Liang, Huanhuan Zhang, 2014, Medical Oncology.

Significance of logistic regression scoring model based on natural killer cell-mediated cytotoxic pathway in the diagnosis of colon cancer

X. Zhan, Jia-feng Liang, Z. Ye, 2023, Frontiers in Immunology.

Prognostic value of kisspeptin expression in nasopharyngeal carcinoma

Qiong Zhang, Yin Liang, Huanhuan Zhang, 2014, The Laryngoscope.

Identifying tumor antigens and immune subtypes of gastrointestinal MALT lymphoma for immunotherapy development

Xu Zhang, Huanhuan Zhang, K. Ding, 2022, Frontiers in Oncology.